QLT, Inc. (USA) (NASDAQ:QLTI)

CAPS Rating: 3 out of 5

A biopharmaceutical company dedicated to the discovery, development and commercialization of innovative therapies.

Recs

0
Player Avatar analyst86 (< 20) Submitted: 4/2/2008 9:26:59 PM : Underperform Start Price: $3.81 QLTI Score: -98.22

No new drugs, high inherent risk, pending legal action.

Report this Post Reply

Featured Broker Partners


Advertisement